Veracity Capital LLC Vertex Pharmaceuticals Inc Transaction History

Veracity Capital LLC

$253 Million
Q1 2025

A detailed history of Veracity Capital LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Veracity Capital LLC holds 2,102 shares of VRTX stock, worth $927,612. This represents 0.4% of its overall portfolio holdings.

Number of Shares

2,102

Previous 2,019 4.11%

Holding current value

$927,612

Previous $813,000 25.34%

% of portfolio

0.4%

Previous 0.3%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	BUY	$402.49 - $513.76 $33,406 - $42,642	83 Added 4.11%	2,102 $1.02 Million
Q4 2024 Jan 17, 2025	BUY	$396.64 - $516.74 $159,052 - $207,212	401 Added 24.78%	2,019 $813,000
Q3 2024 Oct 18, 2024	BUY	$460.0 - $505.78 $106,720 - $117,340	232 Added 16.74%	1,618 $752,000
Q2 2024 Jul 22, 2024	SELL	$392.81 - $485.53 $11,784 - $14,565	-30 Reduced 2.12%	1,386 $649,000
Q1 2024 Apr 19, 2024	BUY	$407.69 - $446.08 $72,161 - $78,956	177 Added 14.29%	1,416 $591,000
Q4 2023 Jan 22, 2024	BUY	$343.0 - $410.68 $18,522 - $22,176	54 Added 4.56%	1,239 $504,000
Q3 2023 Oct 25, 2023	BUY	$338.18 - $362.46 $16,570 - $17,760	49 Added 4.31%	1,185 $412,000
Q2 2023 Jul 20, 2023	BUY	$314.42 - $351.91 $7,860 - $8,797	25 Added 2.25%	1,136 $399,000
Q1 2023 Apr 06, 2023	BUY	$283.23 - $323.1 $5,098 - $5,815	18 Added 1.65%	1,111 $350,000
Q4 2022 Jan 17, 2023	BUY	$285.76 - $321.48 $21,717 - $24,432	76 Added 7.47%	1,093 $0
Q3 2022 Oct 17, 2022	BUY	$273.83 - $305.53 $278,485 - $310,724	1,017 New	1,017 $294,000
Q4 2020 Jan 25, 2021	SELL	$207.01 - $276.09 $225,640 - $300,938	-1,090 Closed	0 $0
Q3 2020 Oct 21, 2020	BUY	$255.65 - $303.1 $51,130 - $60,620	200 Added 22.47%	1,090 $297,000
Q2 2020 Jul 13, 2020	BUY	$225.48 - $295.8 $200,677 - $263,262	890 New	890 $258,000

Others Institutions Holding VRTX

# of Institutions

1,834

Shares Held

233M

Call Options Held

1.38M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $113B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veracity Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veracity Capital LLC with notifications on news.

Account

Veracity Capital LLC Vertex Pharmaceuticals Inc Transaction History